From advanced pharmaceutical distribution to an indispensable part of community healthcare
First written in FY2016. 28 of 33 entries say "Restated". Latest entry: 2026-08-06.
No other company in this theme has enough history to compare yet.
- 2026-08-06RestatedEarnings
「Against this backdrop, in April 2025 the Company launched the "Medium-Term Management Plan 2027 – Move on to the Next Stage –" (FY2025–FY2027). As a company listed on the TSE Prime Market, it is incorporating into its group management a full-fledged focus on the cost of capital, and is working to strengthen the profitability of existing businesses, review the businesses themselves, and make proactive growth investments, with the aim of achieving sustainable growth for the Group and enhancing corporate value over the medium to long term.」
Reconfirms the policy under Medium-Term Management Plan 2027 of group management focused on the cost of capital, reviewing existing businesses and making growth investments. - FY2026RestatedAnnual report
「FY2035 (fiscal year ending March 2036) Revenue: pharmaceutical wholesale business 80%, healthcare-related businesses 20% Operating profit: pharmaceutical wholesale business 60%, healthcare-related businesses 40%」
The company reaffirmed the target revenue and operating profit mix by business under Long-Term Vision 2035 and its direction of expanding healthcare-related businesses. - 2026-05-14AdvancedEarnings
「Against this backdrop, in April 2025 the Company launched the "Medium-Term Management Plan 2027 – Move on to the Next Stage –" (FY2025–FY2027). As a company listed on the TSE Prime Market, it is incorporating into its group management a full-fledged focus on the cost of capital, and is working to strengthen the profitability of existing businesses, review the businesses themselves, and make proactive growth investments, with the aim of achieving sustainable growth for the Group and enhancing corporate value over the medium to long term.」
Describes specifically the execution of Medium-Term Management Plan 2027 as part of group management, including the review of existing businesses and growth investments. - FY2025AdvancedAnnual report
「The practical initiatives for Long-Term Vision 2035 have been changed as follows. / ・Enhancement of logistics functions ・Reform of the pharmaceutical wholesale business ・Expansion of medical-related products ・Entry into the pharmaceutical manufacturing business ・Strengthening of the rental business ・Strengthening collaboration with government and local authorities ・Strengthening the pharmacy business and veterinary pharmaceutical wholesale business ・Development of life-support businesses」
While maintaining the target revenue and operating profit mix under Long-Term Vision 2035, the company has defined specific practical initiatives including entry into the pharmaceutical manufacturing business, the rental business, collaboration with government and local authorities, the pharmacy and veterinary pharmaceutical wholesale businesses, and life-support businesses. - FY2025-H1RestatedAnnual report
「Against this backdrop, in the final year of the Fifth Medium-Term Management Plan, we will complete the various initiatives and achieve the earnings plan, while working as one Group to realize “Long-Term Vision 2035: Across boundaries, beyond medicine, transforming the future of healthcare by ‘connecting.’”」
In the final year of the Fifth Medium-Term Management Plan, the company reaffirmed its policy of pursuing the realization of Long-Term Vision 2035. - FY2024AdvancedAnnual report
「Long-Term Vision 2035: target business mix by revenue and operating profit / FY2035 (fiscal year ending March 2036) Revenue: pharmaceutical wholesale business 80%, healthcare-related businesses 20% Operating profit: pharmaceutical wholesale business 60%, healthcare-related businesses 40%」
For Long-Term Vision 2035, the company specifies the target revenue and operating profit mix for the pharmaceutical wholesale business and healthcare-related businesses in FY2035. - FY2024-Q3RestatedAnnual report
「In light of these changes in market structure and the management environment, the Group formulated “Long-Term Vision 2035” beginning with the fiscal year ending March 2024: “Across boundaries, beyond medicine, transforming the future of healthcare by ‘connecting.’” Under this long-term vision, we will build a sustainable distribution system for pharmaceuticals and medical-related products through independence and collaboration, while expanding healthcare-related businesses to help address social issues and extend healthy life expectancy.」
The company reaffirmed the slogan of Long-Term Vision 2035, the establishment of a sustainable distribution system through independence and collaboration, and the expansion of healthcare-related businesses. - FY2024-Q2RestatedAnnual report
「In light of these changes in market structure and the management environment, the Group formulated “Long-Term Vision 2035” beginning with the fiscal year ending March 2024: “Across boundaries, beyond medicine, transforming the future of healthcare by ‘connecting.’” Under this long-term vision, we will build a sustainable distribution system for pharmaceuticals and medical-related products through independence and collaboration, while expanding healthcare-related businesses to help address social issues and extend healthy life expectancy.」
The company reaffirmed the slogan of Long-Term Vision 2035, the establishment of a sustainable distribution system through independence and collaboration, and the expansion of healthcare-related businesses. - FY2024-Q1RestatedAnnual report
「In light of these changes in market structure and the management environment, the Group formulated “Long-Term Vision 2035” beginning with the fiscal year ending March 2024: “Across boundaries, beyond medicine, transforming the future of healthcare by ‘connecting.’” Under this long-term vision, we will build a sustainable distribution system for pharmaceuticals and medical-related products through independence and collaboration, while expanding healthcare-related businesses to help address social issues and extend healthy life expectancy.」
The company reaffirmed the slogan of Long-Term Vision 2035 and set out as specific directions the establishment of a sustainable distribution system through independence and collaboration, expansion of healthcare-related businesses, and contributions to addressing social issues and extending healthy life expectancy. - FY2023ReframedAnnual report
「In light of these changes in market structure and the management environment, the Group formulated a new “Long-Term Vision 2035” beginning with the fiscal year ending March 2024. / Across boundaries, beyond medicine, transforming the future of healthcare by “connecting”」
The company has reframed its long-term corporate vision from the former long-term vision for 2025 as “Long-Term Vision 2035,” looking ahead to 2035. - FY2023-Q1RestatedAnnual report
「We will continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The company continues to uphold its intended role in local healthcare for 2025 after the start of the Fifth Medium-Term Management Plan. - FY2022RestatedAnnual report
「Under the Fifth Medium-Term Management Plan, we will continue pursuing the long-term vision set out in the Third Medium-Term Management Plan for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for where we aim to be in 2025 continues under the Fifth Medium-Term Management Plan. - FY2022-Q3RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 2025 continues in the final year of the Fourth Medium-Term Management Plan. - FY2022-Q2RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 2025 continues in the final year of the Fourth Medium-Term Management Plan. - FY2022-Q1RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 2025 continues to be upheld in the final year of the Fourth Medium-Term Management Plan. - FY2021-Q3RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The company has reaffirmed the long-term vision for 2025 and its policy of becoming indispensable to local healthcare through the strategic provision of products and services that support medical care and nursing care. - FY2021-Q2RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 2025 continues in the second year of the Fourth Medium-Term Management Plan. - FY2021-Q1RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
In the second year of the Fourth Medium-Term Management Plan, the company continues to pursue the long-term vision for 2025 and its policy of becoming indispensable to local healthcare through the strategic provision of products and services. - FY2020RestatedAnnual report
「We will continue pursuing under the Fourth Medium-Term Management Plan the long-term vision set out in the Third Medium-Term Management Plan for where we aim to be in 2025. / “Becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care”」
The company continues to pursue the long-term vision for where it aims to be in 2025 and its direction of becoming indispensable to local healthcare through the strategic provision of products and services. - FY2020-Q3RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we will continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The company has reaffirmed the long-term vision for where it aims to be in 2025 and its policy of becoming an indispensable presence in local healthcare through the strategic provision of products and services that support medical care and nursing care. - FY2020-Q2RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we will continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for where we aim to be in 2025 continues under the Fourth Medium-Term Management Plan. - FY2020-Q1RestatedAnnual report
「Under the Fourth Medium-Term Management Plan, we will continue pursuing the long-term vision for where we aim to be in 2025: “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for where we aim to be in 2025 continues after the start of the Fourth Medium-Term Management Plan. - FY2019RestatedAnnual report
「We will continue pursuing under the Fourth Medium-Term Management Plan the long-term vision set out in the Third Medium-Term Management Plan for where we aim to be in 2025. / “Becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care”」
The long-term vision for where we aim to be in 2025 continues under the Fourth Medium-Term Management Plan. - FY2019-Q3RestatedAnnual report
「Under the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
In the final year of the Third Medium-Term Management Plan, the company also reaffirmed the long-term vision for 10 years from now and its direction of becoming an indispensable presence in local healthcare through the strategic provision of products and services. - FY2019-Q2RestatedAnnual report
「Against this backdrop, the Group reached the final year of the Third Medium-Term Management Plan, covering the 3 years from the fiscal year ended March 2017 through the fiscal year ended March 2019. Under the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 10 years from now continues to be upheld in the final year of the Third Medium-Term Management Plan. - FY2018RestatedAnnual report
「As the long-term vision for where we aim to be in 10 years, we set out “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The company has reaffirmed the long-term vision for 10 years from now and its direction of contributing to local healthcare through medical and nursing-care products and services. - FY2018-Q3RestatedAnnual report
「Under the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The company continues to uphold the long-term vision for 10 years from now and its intended role in local healthcare through the strategic provision of products and services that support medical care and nursing care. - FY2018-Q2RestatedAnnual report
「Under the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 10 years from now continues to be upheld in the second year of the Third Medium-Term Management Plan. - FY2018-Q1RestatedAnnual report
「Under the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 10 years from now continues to be upheld in the second year of the Third Medium-Term Management Plan. - FY2017RestatedAnnual report
「As the long-term vision for where we aim to be in 10 years, we set out “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 10 years from now continues to be presented in the annual report. - FY2017-Q2RestatedAnnual report
「First, ahead of the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 10 years from now was reaffirmed under the Third Medium-Term Management Plan. - FY2017-Q1RestatedAnnual report
「We launched the Third Medium-Term Management Plan, covering the 3 years from the fiscal year ended March 2017 through the fiscal year ended March 2019. First, ahead of the Third Medium-Term Management Plan, we set out as our long-term vision for where we aim to be in 10 years “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
The long-term vision for 10 years from now was reaffirmed and has continued to be upheld since the start of the Third Medium-Term Management Plan. - FY2016First statedAnnual report
「The long-term vision was “Enhancing our presence in the industry and pursuing advanced pharmaceutical distribution.” As the long-term vision for where we aim to be in 10 years, we set out “becoming an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care.”」
In addition to the former goals of enhancing industry presence and pursuing advanced distribution, the company sets out its intended role in local and community healthcare in 10 years.